The Department of Defense reportedly expects to increase its use of unmanned aerial systems (“drones”) by nearly 50% in the next few years. At the same time, however, the rate of DoD’s procurement of drones is projected to decline sharply from FY2016-2020.
The Congressional Research Service takes note of the seeming contradiction and proposes several possible explanations to resolve it. See How Many UAVs for DoD?, CRS Insights, August 27, 2015.
Other new and updated CRS publications that became public last week include the following.
Policy Implications of the Internet of Things, CRS Insights, August 25, 2015
Health Insurance: Small is the New Large, CRS Insights, August 26, 2015
Gold King Mine Spill May Renew Interest in “Good Samaritan” Legislation, CRS Insights, August 27, 2015
Financial Regulatory Improvement Act Included in Senate Appropriations Bill, CRS Insights, August 27, 2015
Terrorism Victims Sue to Enjoin Sanctions Relief under the Iran Nuclear Agreement, CRS Legal Sidebar, August 27, 2015
District of Columbia: A Brief Review of Provisions in District of Columbia Appropriations Acts Restricting the Funding of Abortion Services, updated August 27, 2015
Drug Testing and Crime-Related Restrictions in TANF, SNAP, and Housing Assistance, updated August 28, 2015
The Patient Protection and Affordable Care Act’s Essential Health Benefits (EHB), August 27, 2015
Navy Ship Names: Background For Congress, updated August 26, 2015
Nearly 150 organizations and government officials have endorsed the call to action and solutions for extreme heat, now public at HeatAgenda.US Washington, D.C. – July 7, 2026 – As millions of Americans continue to struggle to stay cool following one of the hottest Independence Day holidays on record, the Federation of American Scientists (FAS), one […]
Addressing rising heat will take all of us. Together, we can create heat-safe homes, workplaces, schools, childcare facilities, and communities – the backbone of a heat-ready nation.
We sat down with biomedical research pioneer Lee Hood to talk moonshots, metascience in medicine, and the Human Phenome Initiative.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.